Cargando…
Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza™): results of a qualitative survey
PURPOSE: The purpose of this study is to evaluate the patient experience of sustained release dexamethasone intracanalicular insert (Dextenza™) following cataract surgery as part of a Phase III clinical trial program. METHODS: This cross-sectional, qualitative evaluation involved individual intervie...
Autores principales: | Gira, Joseph P, Sampson, Reginald, Silverstein, Steven M, Walters, Thomas R, Metzinger, Jamie Lynne, Talamo, Jonathan H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352246/ https://www.ncbi.nlm.nih.gov/pubmed/28331295 http://dx.doi.org/10.2147/PPA.S126283 |
Ejemplares similares
-
In Clinic Optometrist Insertion of Dextenza (Dexamethasone Ophthalmic Insert 0.4mg) Prior to Cataract Surgery: The PREPARE Study
por: Ibach, Mitchel J, et al.
Publicado: (2022) -
Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults
por: Blizzard, Charles, et al.
Publicado: (2021) -
Early Real-World Physician Experience with an Intracanalicular Dexamethasone Insert
por: Matossian, Cynthia, et al.
Publicado: (2022) -
Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy
por: Brooks, Cassandra C, et al.
Publicado: (2020) -
Prospective, Randomized, Fellow Eye-Controlled Study of Postoperative Pain and Inflammation Control with an Intracanalicular Dexamethasone 0.4 mg Ophthalmic Insert Following Small Incision Lenticule Extraction
por: Jee, Kathleen J, et al.
Publicado: (2022)